Trethera

Sherman Oaks, CA · Founded 2015 · Privately Held (backing)

Developer of nucleotide metabolism drugs designed to provide treatment for cancer and autoimmune diseases. Trethera is based in Sherman Oaks, CA and was founded in 2015. Its last reported valuation was $13.1 million in Apr 2019. It has raised $35 million across 7 recorded rounds; the latest was a $250,000 seed round in Apr 2025.

Last reported valuation
$13.1M
Oct 2026
Priced at
—
Total raised
$35.0M
Last round
Seed Round
Apr 2025
What is Trethera worth?
$13.1Mlast reported valuation · Oct 2026

Trethera's last reported valuation, Apr 2019. Nothing priced has surfaced since.

Free account
More of Trethera with a free account
  • ·Watch Trethera: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Trethera funding history

7 rounds
DateRoundRaisedPost-money
Apr 2025Seed Round$250K▮
Jun 2021Seed Round$3.8M▮
Feb 2020Seed Round$3.3M▮
Apr 2019Seed Round$581K▮
Mar 2019Early Stage VC$8.1M▮
Feb 2017Seed Round$4.2M▮
+ 1 earlier rounds · a free account shows the full history
Unlock post-money valuations

Membership and data by Private Market View

Trethera valuation

Trethera's last reported valuation was $13.1 million in Apr 2019. No priced round, secondary trade or fund mark has surfaced since.

How much has Trethera raised?

Trethera has raised $35 million across 7 recorded rounds since 2016. The largest was an $8.1 million early-stage round in Mar 2019; the most recent was a $250,000 seed round in Apr 2025.

Trethera has filed 8 Form Ds with the SEC since 2016, most recently in May 2025 ($250,000 sold to 1 investor).

How Trethera's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Trethera, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Trethera

What is Trethera worth?
Trethera is valued at $13.1M as of Oct 2026. Trethera's last reported valuation, Apr 2019. Nothing priced has surfaced since.
How much has Trethera raised?
Trethera has raised $35.0M in total funding across 7 recorded rounds.
When did Trethera last raise?
Trethera last raised in Apr 2025 (Seed Round), raising $250K.